Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 26:6:1018-1030.
doi: 10.1016/j.toxrep.2019.09.012. eCollection 2019.

Safety evaluation of calcium L-methylfolate

Affiliations

Safety evaluation of calcium L-methylfolate

K E Niederberger et al. Toxicol Rep. .

Abstract

Calcium L-methylfolate (L-5-MTHF-Ca; CAS Number 151533-22-1) is a source of folate and an alternative to folic acid for use in human food and food supplements. The safety of L-5-MTHF-Ca was evaluated by testing for genotoxicity, subchronic and prenatal developmental toxicity. In in vitro assays L-5-MTHF-Ca was not mutagenic and did not induce other chromosomal events. Additionally, L-5-MTHF-Ca was not genotoxic in the in vivo micronucleus test nor did it induce DNA damage in rat liver cells. In a subchronic toxicity study, rats administered up to 400 mg/kg bw/day of L-5-MTHF-Ca via oral gavage for 13 weeks had no treatment-related mortalities, and no treatment-related effects were identified on behaviour, body weight, food consumption, ophthalmology, haematology, or organ weights. No treatment-related macroscopic or histopathological findings were observed. Calcium and sodium levels increased with increasing dosage, however the slight increases were within historical control ranges and reversible after the recovery period. L-5-MTHF-Ca is neither teratogenic nor embryotoxic. Based on the results of the in vitro and in vivo studies, the safe use of L-5-MTHF-Ca as an ingredient in foods is supported. The no observed adverse effect level was the highest dose in the subchronic toxicity study, i.e. 400 mg/kg bw/day for male and female rats.

Keywords: 5-MTHF, 5-methyltetrahydrofolate; ANOVA, analysis of variance; BaP, benzo[a]pyrene; Calcium L-methylfolate; Developmental toxicity; EFSA, European Food Safety Authority; GD, gestation day; GLP, Good Laboratory Practice; GRAS, generally recognized as safe; Genotoxicity; HPLC, High Performance Liquid Chromatography; JECFA, Joint FAO/WHO Expert Committee on Food Additives; L-5-MTHF-Ca; L-5-MTHF-Ca, calcium L-methylfolate; MTT, 3-[45-dimethylthiazole-2-yl]-2,5-diphenylbromide; NNG, net grains/nucleus; NOAEL, No Observed Adverse Effect Level; OECD, Organisation for Economic Co-operation and Development; TFT, 5-trifluorothymidine; Toxicity; USP, United States Pharmacopeia; WE-I, Williams E medium-Incomplete; bw, body weight.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Bailey L.B., Gregory J.F. Folate metabolism and requirements. J. Nutr. 1999;129:779–782. - PubMed
    1. Shrubsole M.J., Jin F., Dai Q., Shu X.O., Potter J.D., Hebert J.R., Gao Y.T., Zheng W. Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res. 2001;61:7136–7141. - PubMed
    1. Robinson K., Arheart K., Refsum H., Brattström L., Boers G., Ueland P., Rubba P., Palma-Reis R., Meleady R., Daly L., Witteman J., Graham I. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation. 1998;97:437–443. - PubMed
    1. Laurence K.M., James N., Miller M.H., Tennant G.B., Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br. Med. J. (Clin. Res. Ed.) 1981;282:1509–1511. - PMC - PubMed
    1. Witthöft C.M., Forssén K., Johannesson L., Jägerstad M. Folates - food sources, analyses, retention and bioavailability. Näringsforskning. 1999;43:138–146.